Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity

Human Pathology

Volumn 44, Issue 8, 2013, Pages 1597-1604

  De Graaff, Marieke A ^a   Cleton Jansen, Anne Marie ^a   Szuhai, Károly ^a   Bovée, Judith V M G ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

catenin; Leiomyoma; Leiomyosarcoma; MED12 mutation; Wnt pathway

Indexed keywords

BETA CATENIN; MEDIATOR COMPLEX; MEDIATOR COMPLEX SUBUNIT 12; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARCINOGENESIS; DNA EXTRACTION; EXON; FEMALE; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MITOSIS INDEX; MONOSOMY X; MUSCLE TUMOR; MUTATIONAL ANALYSIS; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; SPINDLE CELL SARCOMA; TISSUE MICROARRAY; TRICHILEMMOMA; UTERUS MYOMA; UTERUS SARCOMA; WNT SIGNALING PATHWAY; X CHROMOSOME;

Β-CATENIN; LEIOMYOMA; LEIOMYOSARCOMA; MED12 MUTATION; WNT-PATHWAY;

ABDOMINAL NEOPLASMS; ADULT; ANGIOMYOMA; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LEIOMYOMA; LEIOMYOSARCOMA; MEDIATOR COMPLEX; MUTATION; SMOOTH MUSCLE TUMOR; SOFT TISSUE NEOPLASMS; TISSUE ARRAY ANALYSIS; UTERINE NEOPLASMS;

EID: 84880325091     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.01.006     Document Type: Article

References (36)

1. S. Okolo Incidence, aetiology and epidemiology of uterine fibroids Best Pract Res Clin Obstet Gynaecol 22 2008 571 588
2. E.A. Stewart Uterine fibroids Lancet 357 2001 293 298
3. G.P. Flake, J. Andersen, and D. Dixon Etiology and pathogenesis of uterine leiomyomas: a review Environ Health Perspect 111 2003 1037 1054
4. D. Weedon, R.M. Williamson, and J.W. Patterson Smooth and skeletal muscle tumours P.E. LeBoit, World Health Organization Classification of Tumours. Pathology and Genetics of Skin Tumours 2006 IARC Press Lyon 250 253
5. P. Ramesh, S.R. Annapureddy, F. Khan, and P.D. Sutaria Angioleiomyoma: a clinical, pathological and radiological review Int J Clin Pract 58 2004 587 591
6. C.D.M. Fletcher, K.K. Unni, and F. Mertens World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone 2002 IARC Press Lyon
7. Y. Hennig, U. Deichert, and C. Stern Structural aberrations of chromosome 6 in three uterine smooth muscle tumors Cancer Genet Cytogenet 87 1996 148 151
8. C.S. Ishwad, R.E. Ferrell, and J. Davare Molecular and cytogenetic analysis of chromosome 7 in uterine leiomyomas Genes Chromosomes Cancer 14 1995 51 55
9. N. Pandis, S. Heim, and G. Bardi Chromosome analysis of 96 uterine leiomyomas Cancer Genet Cytogenet 55 1991 11 18
10. W.J. Van de Ven Genetic basis of uterine leiomyoma: involvement of high mobility group protein genes Eur J Obstet Gynecol Reprod Biol 81 1998 289 293
11. M. Schoenberg-Fejzo, H.R. Ashar, and K.S. Krauter Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas Genes Chromosomes Cancer 17 1996 1 6
12. A.J. Williams, W.L. Powell, T. Collins, and C.C. Morton HMGI(Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm Am J Pathol 150 1997 911 918
13. N. Mäkinen, M. Mehine, and J. Tolvanen MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas Science 334 2011 252 255
14. D.N. Markowski, S. Bartnitzke, and T. Loning MED12 mutations in uterine fibroids - their relationship to cytogenetic subgroups Int J Cancer 131 2012 1528 1536
15. E.M. Je, M.R. Kim, K.O. Min, N.J. Yoo, and S.H. Lee Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors Int J Cancer 131 2012 E1044 E1047
16. M.M. McGuire, A. Yatsenko, and L. Hoffner Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas PLoS One 7 2012 e33251
17. G. Pérot, S. Croce, and A. Ribeiro MED12 alterations in both human benign and malignant uterine soft tissue tumors PLoS One 7 2012 e40015
18. N. Makinen, H.R. Heinonen, and S. Moore MED12 exon 2 mutations are common in uterine leiomyomas from South African patients Oncotarget 2 2011 966 969
19. Y. Takagi, and R.D. Kornberg Mediator as a general transcription factor J Biol Chem 281 2006 80 89
20. S. Akoulitchev, S. Chuikov, and D. Reinberg TFIIH is negatively regulated by cdk8-containing mediator complexes Nature 407 2000 102 106
21. D.J. Taatjes The human Mediator complex: a versatile, genome-wide regulator of transcription Trends Biochem Sci 35 2010 315 322
22. M.T. Knuesel, K.D. Meyer, A.J. Donner, J.M. Espinosa, and D.J. Taatjes The human CDK8 subcomplex is a histone kinase that requires Med12 for activity and can function independently of mediator Mol Cell Biol 29 2009 650 661
23. S. Kim, X. Xu, A. Hecht, and T.G. Boyer Mediator is a transducer of Wnt/beta-catenin signaling J Biol Chem 281 2006 14066 14075
24. G. Farshid, M. Pradhan, J. Goldblum, and S.W. Weiss Leiomyosarcoma of somatic soft tissues: a tumor of vascular origin with multivariate analysis of outcome in 42 cases Am J Surg Pathol 26 2002 14 24
25. R. Koivisto-Korander, J.I. Martinsen, E. Weiderpass, A. Leminen, and E. Pukkala Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: results from NORDCAN and NOCCA databases Maturitas 72 2012 56 60
26. J.C. Hodge, and C.C. Morton Genetic heterogeneity among uterine leiomyomata: insights into malignant progression Hum Mol Genet 16 Spec No 1 2007 R7 R13
27. C. Sreekantaiah, J.R. Davis, and A.A. Sandberg Chromosomal abnormalities in leiomyosarcomas Am J Pathol 142 1993 293 305
28. Federation of Medical Scientific Societies. Code for proper secondary use of human tissue in the Netherlands. Version 2002. http://www.fmwv.nl/ gedragscodes/goedgebruik/CodeProperSecondaryUseOfHumanTissue.pdf.
29. J.V.M.G. Bovee, A.M. Cleton-Jansen, and N.J. Kuipers-Dijkshoorn Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma Genes Chromosomes Cancer 26 1999 237 246
30. S. Rossi, K. Szuhai, and M. Ijszenga EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma Clin Cancer Res 13 2007 7322 7328
31. C.G. Trope, V.M. Abeler, and G.B. Kristensen Diagnosis and treatment of sarcoma of the uterus. A review Acta Oncol 51 2012 694 705
32. K. Bodner, B. Bodner-Adler, O. Kimberger, K. Czerwenka, and K. Mayerhofer Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors Fertil Steril 81 2004 1062 1066
33. C.E. de Andrea, C.M. Reijnders, and H.M. Kroon Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT Oncogene 31 2012 1095 1104
34. M. Ilyas, and I.P. Tomlinson The interactions of APC, E-cadherin and beta-catenin in tumour development and progression J Pathol 182 1997 128 137
35. P.S. Tanwar, H.J. Lee, and L. Zhang Constitutive activation of beta-catenin in uterine stroma and smooth muscle leads to the development of mesenchymal tumors in mice Biol Reprod 81 2009 545 552
36. E. Deutscher, and Y.H. Hung-Chang Essential roles of mesenchyme-derived beta-catenin in mouse Mullerian duct morphogenesis Dev Biol 307 2007 227 236